Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Impact of Glucose Lowering Therapies on Circulating Endothelial Progenitor Cells and Its Mobilising Factor Stromal Derived Factor-1α in Patients With Type 2 Diabetes (IGLOOS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02694575
Recruitment Status : Completed
First Posted : February 29, 2016
Last Update Posted : April 17, 2019
Sponsor:
Collaborator:
University Hospitals, Leicester
Information provided by (Responsible Party):
University of Leicester

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 12, 2017
Actual Study Completion Date : August 31, 2018
Publications:
IDF. IDF diabetes atlas 5th Edition. 2011.
DUK. Diabetes in the UK 2010 Key Satistics on Daibetes. 2010: 1-21.